Objectives: Methicillin resistance in staphylococci is mediated by the mecA gene, which is carried on the staphylococcal cassette chromosome mec (SCCmec). SCCmec is responsible for vertical and horizontal transfer of methicillin resistance. Horizontal transfer implies first SCCmec excision from the chromosome. Site-specific excision is catalysed by the Ccr recombinases, which are encoded by ccrAB genes located on the cassette. The aim of this study is to determine the promoter activity of ccrAB genes in individual cells of methicillinresistant Staphylococcus aureus (N315, COL and MW2) and Staphylococcus epidermidis (RP62A). One mutant cured of its SCCmec (N315EX) was also used. Exposure to various stresses was included in the study.
Introduction
In Staphylococcus spp. resistance to methicillin and to virtually all b-lactam drugs is mediated by the expression of the mecA gene, which encodes low-affinity penicillin-binding protein A, or PBP2A. 1 The mecA gene is carried by a genomic island named staphylococcal cassette chromosome mec (SCCmec), which is responsible for both vertical and horizontal transfer of methicillin resistance. It was originally believed that worldwide spread of methicillin-resistant Staphylococcus aureus (MRSA) was solely due to clonal expansion of a few successful strains, implying that de novo acquisition of SCCmec was extremely rare. 2 However, more recent studies indicate that lateral spread of SCCmec is more frequent than expected. 3, 4 This is substantiated both by the fact that almost identical cassettes are present in unrelated staphylococcal strains-and even in different staphylococcal species-and by the presence of different types of SCCmec in closely related strains. 5 -7 To be transferred, SCCmec must first be excised from the chromosome of the donor strain. Site-specific excision of SCCmec is catalysed by the Ccr recombinases, which are large serine recombinases of the resolvase/invertase family and are encoded on the SCCmec cassette. 8 Three phylogenetically distinct ccr genes have been found so far on different cassettes. Certain SCCmec cassettes carry the ccrA and ccrB genes (ccrAB), which are part of the same transcription unit, whereas other cassettes carry the ccrC gene, which shares less than 50% sequence similarity with ccrAB. Several allotypes (sequence similarity below 85%) have been described for ccrA and ccrB and are used for classification of their cognate SCCmec cassettes. In contrast, only one allotype was found for the ccrC gene. 9 Site-specific excision/integration of SCCmec takes place at the 5 ′ end of orfX, a highly conserved gene located near the origin of replication in S. aureus. Integration involves a 15 bp core sequence (attB), which recombines with the cognate 15 bp core sequence located on the SCCmec (attS) resulting, upon integration, in two direct repeats (attR and attL) flanking the element. 8 In addition, accessory sequences located near the attS sites, which form imperfect inverted repeats of various sizes, seem also to play a role in site-specific integration/excision in many SCCmec. 10, 11 Interestingly, CcrAB recombinases do not display cassette specificity, as all the allotypes are able to excise SCCmec of different types. 12 Conversely, CcrC recombinases are specific to their own SCCmec.
11
Spontaneous SCCmec excision has been observed on several occasions both in vivo and in vitro.
12 -15 For instance, overexpression of plasmid-located ccrAB genes generally leads to SCCmec excision and results in conversion of MRSA into methicillinsusceptible S. aureus (MSSA). 8 Moreover, b-galactosidase assays and quantitative RT-PCR studies showed that b-lactams and vancomycin increased transcription from ccrAB promoters of strains MW2 and N315. 16 This could favour the propagation of SCCmec via a two-step scenario. First, b-lactam drugs in the environment would select for methicillin-resistant staphylococci, thus promoting the expansion of the SCCmec reservoir. Second, transfer of SCCmec from this reservoir into new staphylococci would generate new methicillin-resistant strains capable of further amplifying the pool of SCCmec. In such a scenario, the optimal setting implies that not all individuals of the donor population do excise their cassette simultaneously, because they would become methicillin susceptible and thus be destroyed by the drug, but that only a few individuals commit this suicide, sacrificing themselves to transfer SCCmec into new recipient strains.
Here we tested this hypothesis by using promoter-green fluorescent protein (gfp) fusions to measure the expression of ccrAB genes in individual cells of various strains of MRSA carrying different types of SCCmec cassettes. Moreover, we also examined the methicillin-resistant Staphylococcus epidermidis strain RP62A, as more and more evidence suggests that coagulase-negative staphylococci are the reservoir of SCCmec for S. aureus.
13,17,18

Materials and methods
Bacterial strains, media and culture conditions
Bacterial strains and plasmids used in this study are listed in Table 1 . Escherichia coli strain DH5a, which was routinely used for plasmid propagation and cloning experiments, was cultivated on Luria-Bertani (LB) medium (Becton Dickinson, Sparks, MD, USA) supplemented with 100 mg/L ampicillin (AppliChem, Darmstadt, Germany) at 378C. S. aureus strains were grown with aeration in Trypticase soy broth (TSB) (Difco Laboratories, Detroit, MI, USA) in a rotating incubator (at 180 rpm) at 378C. For all experiments, bacterial cultures were inoculated with a 1/100 dilution of an overnight culture. If required, tetracycline and erythromycin (AppliChem) were added at a final concentration of 10 mg/L for plasmid propagation and 5 mg/L for flow cytometry analysis. Oxacillin was commercially purchased and used at the sub-MIC concentration pPGFP-N315 P ccrAB N315-gfpmut2 fusion cloned in pCN36; tet(M) this study pPGFP-MW2 P ccrAB MW2-gfpmut2 fusion cloned in pCN36; erm(C) this study pPGFP-COL P ccrAB COL-gfpmut2 fusion cloned in pCN36; erm(C) this study pPGFP-COL-Tc P ccrAB COL-gfpmut2 fusion cloned in pCN36; tet(M) this study pPGFP-RP62A P ccrAB RP62A-gfpmut2 fusion cloned in pCN36; tet(M) this study pNEG-tet(M) P NEG -gfpmut2 fusion cloned in pCN36; used as negative control this study pNEG-ermC P NEG -gfpmut2 fusion cloned in pCN36; tet(M) replaced with erm(C); used as negative control this study pGFPS10-tet(M) P PS10 -gfpmut2 fusion cloned in pCN36; used as positive control this study pGFPS10-ermC P PS10 -gfpmut2 fusion cloned in pCN36; tet(M) replaced with erm(C); used as positive control this study Stojanov et al. 
DNA manipulations
For S. aureus and S. epidermidis, genomic DNA was extracted using a protocol adapted from Bae et al. 24 Briefly, 3 mL of an overnight culture was harvested and resuspended in 50 mL of Tris -EDTA buffer (10 mM Tris-Cl, pH 7.5, and 1 mM EDTA) supplemented with lysostaphin (final concentration 0.5 mg/mL). After 30 min of incubation at 378C, 300 mL of 'Nuclei lysis solution' (Promega Corp., Madison, WI, USA) was added and the cell suspensions were heated at 808C for 10 min. The samples were then treated with RNase and addition of 100 mL of 'Protein precipitation solution' (Promega Corp.) was followed by incubation for 5 min on ice. After centrifugation (48C, 15 600 g), supernatants were collected and 300 mL of isopropanol was used to precipitate the DNA, which was subsequently washed with 70% ethanol, pelleted by centrifugation, air-dried and re-diluted at 48C overnight in 20 mL of elution buffer (Qiagen Inc., Hilden, Germany).
Plasmids were isolated using the QIAprep Spin Miniprep Kit (Qiagen Inc.). For S. aureus, an additional step consisting of lysostaphin treatment (final concentration 0.5 mg/mL) was performed before the lysis step.
Digestions with restriction enzymes (Promega Corp.) were carried out according to the manufacturer's specifications. PCR fragments were purified using the QIAquick PCR Purification Kit (Qiagen Inc.) and gel-bands were purified using the QIAquick Gel Extraction Kit (Qiagen Inc.) according to the manufacturer's protocols. Ligations were performed using 1 mL of T4 ligase (Promega Corp.) according to the manufacturer's specifications.
PCR
GoTaq DNA polymerase (Promega Corp.) was routinely used for colony PCR screening analysis. DNA fragments required for cloning were amplified with KAPA HiFi DNA Polymerase (KAPA Biosystems, Cape Town, South Africa). All reactions were carried out according to the manufacturers' specifications. The primers used in this study are listed in Table 2 .
Construction of translational fusion reporter plasmids
All the promoter-gfp fusion reporters were constructed as follows: specific primer pairs were used to PCR amplify the N315 ccrAB promoter and the gfpmut2 gene. After enzymatic digestion, the two fragments were cloned by three-point ligation in the pCN36 plasmid. All the other plasmid reporters used in the study were made by substituting the N315 ccrAB promoter with their respective promoter ( Table 1) . To calibrate the levels of activity of the ccrAB promoters, a negative control plasmid (pNEG) was constructed by replacing the ccrAB promoter region with a 140 bp DNA fragment of the secA gene (SA2442 in strain N315), and a positive control plasmid (pGFPS10) was constructed by replacing the same region with the constitutive promoter of the rpsJ gene (SA2048 in strain N315).
Microscopy
Epifluorescence microscopy was performed using an Axioskop2 epifluorescence microscope (Zeiss, Germany), with a×100 objective (Plan-NEOFLUAR ×100/1.30 oil, Zeiss). Bacteria from 3 mL aliquots from cultures in the exponential growth phase as described previously 25 were harvested by centrifugation and resuspended in 50 mL of PBS, of which 10 mL was deposited on glass slides and analysed.
Picture files (16-Bit) were scaled with Metamorph software (Visitron Systems, Germany) to visualize the fluorescence signal. GFP fluorescence pictures were digitally coloured using Photoshop 4.0 (Adobe Systems Europe Ltd, Edinburgh, UK) and superimposed on the corresponding phase contrast pictures, in order to visualize cells with an active ccrAB promoter.
Flow cytometry
Flow cytometry was performed with a FACS-Calibur (BD Biosciences, Erembodegem, Belgium), equipped with an air-cooled argon laser (488 nm). GFP fluorescence was recorded in the FL1 (525+15 nm channel). Samples were removed from cultures in the exponential or stationary phase of growth, diluted in PBS in order to not exceed 800 events per second, and the fluorescence of 20 000 events was recorded for each sample. Analysis of flow cytometry data was performed using WinMDI software (version 2.8, Salk Institute, http://facs.scripps.edu/software.html).
Artificial SCCmec excision
SCCmec was cured from S. aureus N315 by using a method from Katayama et al. 8 Briefly, strain N315 was electroporated with the thermosensitive plasmid pSR3-1 (containing ccrAB genes) and transformants were cultured for 24 h at 308C in TSB supplemented with tetracycline, serially diluted and plated on Trypticase soy agar (TSA) supplemented with tetracycline. Single colonies were picked, grown for 24 h at 428C in TSB to Expression of cassette chromosome recombinases 751 JAC promote curing of thermosensitive pSR3-1, and dilutions were plated on plain TSA to screen for colonies susceptible to oxacillin and tetracycline. One double-susceptible colony was purified and the absence of SCCmec in it was confirmed by PCR amplification of the chromosomal junction formed upon excision using the primer pair Excision fw and rev (Table 2) . This isolate was named N315EX and used in further experiments.
Results
Allotype 1 and 2 ccrAB promoters
The expression of ccrAB genes was analysed using gfp translational fusions as depicted in Figure 1(a) . This required first the characterization of the ccr gene promoter regions. Thus, the complete intergenic regions upstream of ccrA, which contain the putative promoter of the ccrAB transcriptional unit, were analysed for all the strains examined in this study (Table 3 ). Figure 1 (b and c) depicts the homologies between these intergenic regions in different strains. The 233 bp promoter regions of strains N315, MW2 and RP62A, which all carry the ccrAB allotype 2, were well conserved, with a sequence similarity of 97% (Figure 1b) . In contrast, the promoter region of strain COL was shorter (i.e. 187 bp), missing the 5 ′ part, and showing a sequence similarity of 77% when compared with N315 (Figure 1c) .
To test whether the activity of the promoters could be modulated in trans by genes from the core chromosome, rather than in cis or in trans by elements from the SCCmec cassette, we also studied the expression of the ccrAB promoters in S. aureus N315EX, from which SCCmec had been deleted.
Microscopy analysis
The activity of the ccrAB promoters was first evaluated by epifluorescence microscopy during the exponential phase of growth (i.e. samples taken after 3 h of inoculation). Figure 2 exemplifies such results with strains N315 and RP62A. It can be seen that both strains expressed GFP uniformly from the positive control vector pGFPS10, whereas cells carrying the negative control pNEG were devoid of fluorescence. In sharp contrast, only Stojanov et al.
a small proportion of the two cell populations showed GFP expression when they carried their specific pPGFP-N315 or pPGFP-RP62A. Most interestingly, roughly similar proportions of cells expressing GFP were observed by microscopy when pPGFP was transformed into the SCCmec-deleted mutant N315EX, indicating that the SCCmec of strain N315 did not contain determinants affecting the activity of the promoter. On the other hand, fluorescence signals were not observed by microscopy when pPGFP-MW2 and pPGFP-COL were introduced into strains MW2 and COL, respectively (data not shown). However, because microscopy results are qualitative and may be dependent on the observer, the experiments described above were repeated using flow cytometry analysis as described below. These, for instance, confirmed the absence of fluorescence in strains MW2 and COL (see Figure 4) .
Quantification of fluorescent cells by flow cytometry and influence of stress conditions on ccrAB expression
Flow cytometry was used to quantitatively assess the proportion of cells expressing the ccrAB promoter under different growth conditions. Figure 3 depicts prototype fluorescence profiles for N315 cells carrying the negative control pNEG (left panel) as well as the same strain expressing pPGFP (right panel). As observed using epifluorescence microscopy, only a minor proportion of the cell population expressed GFP. In order to determine the proportion of GFP-positive cells, we delineated a threshold using the GFP-negative control, as shown in Figure 3 . The experiment was repeated with each of the strains described in Table 3 , tested in either the exponential or stationary phases of growth, and exposed to various stress conditions including growth at 428C and exposure to oxacillin or mitomycin C. Figure 4 presents the details of these results. As a general feature, strains N315, N315EX and RP62A expressed GFP at a sizable level under all test conditions, whereas COL (which had a shorter promoter region of 187 bp versus 233 bp in the other strains) and MW2 (which had an N315-like promoter region) remained essentially below the limit of detection (Figure 4 ).
In the exponential growth phase strains N315, N315EX and RP62A exhibited subpopulations expressing GFP at rates between 2% and 3%, which is compatible with epifluorescence microscopy ( Figure 2) . Similar results were obtained under stress conditions, except for oxacillin treatment, which significantly reduced the GFP expression to 1.5% in strain N315. In contrast, in the stationary growth phase GFP expression was significantly reduced under most conditions, with some exceptions, i.e. for N315 at 428C and RP62A with mitomycin C. 
JAC
It is noteworthy that the results were very similar when plasmid pPGFP-N315 was expressed in parent N315 or in its SCCmec-negative mutant N315EX, thus confirming the results obtained by epifluorescence microscopy and the fact that ccrAB genes were at least partially affected by non-SCCmec genetic determinants.
Finally, to test whether the shorter promoter region of strain COL was responsible for the absence of promoter activity, we transferred its specific expression plasmid (pPGFP-COL-Tc; Table 1 ) into the N315 background and repeated the expression experiment. Figure 5 shows that transfer of COL-specific pPGFP-COL-Tc into N315 or N315EX completely restored promoter activity. Thus, promoter activity was highly dependent on the bacterial background and the shorter COL promoter region was not responsible for its inactivity in the COL background.
Discussion
The present experiments employed a GFP expression system cloned into a low copy number plasmid in order to test the promoter activity of type 1 and 2 ccrAB allotypes in different staphylococcal backgrounds. The results yielded several findings that may help better understand the excision and transmission Stojanov et al.
processes of SCCmec. First, as predicted by the two-step transmission hypothesis discussed in the Introduction section, ccrAB promoter activity was not present simultaneously in all the cells of a culture, but only in a minority of them that represented a small fraction of the whole population. This is logical economics in a relatively primitive transfer system where the donor cell must lose its (presumably) beneficial genomic island in order to transfer it further. The results show that only a few cells in the population were activated for this purpose at a given time, while the remaining bacteria kept their advantageous genotype. This stochastic gene expression system has been referred to as 'bistability' and was described in the transfer of other genomic islands, 26, 27 including the ICEclc in Pseudomonas knackmussi. 28 ICEclc confers the capability to use aromatic compounds (e.g. chlorobenzoates and aminophenols) as carbon sources. Conjugative transfer of this island begins with its excision from the chromosome, which is driven by the activity of the IntB13 integrase promoter. Upstream of that, IntB13 promoter activity is controlled by the InrR protein, which is encoded on the island. Stochastic activation of IntB13 was observed by GFP expression in proportions of cells that increased from 0.1% to 3% between 24 h and 96 h of incubation. This suggested a dependency on cell concentration, and perhaps also on nutrient availability.
The present observations are very reminiscent of the bistability of ICEclc-related transfer in terms of frequency and dependency on growth phase. However, in contrast to ICEclc, the activity of the ccrAB promoters tested herein appeared to be influenced by determinants that were not encoded on the SCCmec cassette, but rather elsewhere on the genome. This was clear from the fact that the type 2 ccrAB promoter region of MRSA N315 was expressed similarly when transformed either into its N315 parent strain or into the isogenic N315EX mutant missing the whole SCCmec cassette. Thus, deletion of SCCmec did not affect promoter activity, which was therefore regulated by other genetic determinants. Moreover, the type 1 ccrAB promoter region of MRSA COL, which was totally inactive in its parental strain, regained full N315-like activity when transformed into MRSA N315 and MSSA N315EX. Thus, factors driving ccrAB gene expression were not only located in the remaining genetic background, but could vary between different strains. Eventually, the fact that the promoter region of the COL ccrAB was functional in N315 restricted critical parts of this region to the 3 ′ end of ≤ 187 bp. Bose et al. 29 described the regulatory excision system of the conjugative island ICEBs1 of Bacillus subtilis. The excisionase gene appeared regulated by an original repressor/antirepressor (immR/immA) system, where the antirepressor acted by proteolytic degradation of the repressor. The system responded to changes in population density, and to DNA-damage-induced SOS response as well. Like in the Pseudomonas ICEclc example, the two genes were located on the ICEBs1. However, they were rather redundant in other B. subtilis mobile genetic elements (MGEs), suggesting that they could act in trans. Moreover, a homologue of the system was found in Staphylococcus haemolyticus.
29
In the present case, we did not find any homologues of the immR/immA system in our strains, either on the SCCmec cassette or on the chromosome. Moreover, we also asked whether there might be differences in the MGE contents of different strains, which might identify a specific MGE that would be present in strain N315 (which could activate ccrAB), but not in strains COL and MW2 (which lacked ccrAB activity), and so drive ccrAB expression in trans in N315. However, this was not the case. Finally, we also asked whether the ccrAB promoter region could carry specific operators for alternative sigma factors, as recently shown in certain S. aureus prophages, 30 but we did not find homologous regions either. Thus, the ccrAB regulatory elements of SCCmec have yet to be identified.
In this regard, and in the context of bistability, one might speculate that the activity of ccrAB in only a minority of cells could serendipitously accompany phenotypic variants in heterogeneous bacterial populations. Population heterogeneity appeared critical to ensure survival of a minority of cells (called persisters) under certain stress conditions, such as antibiotic treatment. 31, 32 Gene expression is different in antibiotic persisters, which are dormant and tolerant to antibiotics, than in vegetative cells, which are active and killed by the drugs. Analogously, it could be that subpopulations expressing ccrAB occur only in specific phenotypic variants along with other housekeeping genes. The question would then arise as to how SCCmec cassettes managed to take advantage of this bacterial regulation system, and why was it different in different strains. More insights into the phylogeny of SCCmec cassette precursors might help to solve this issue.
While the present experiments were not aimed at identifying the precise molecular mechanisms responsible for ccrAB regulation, some clues for them were identified. Indeed, aside from the fact that trans-acting determinants were located outside the SCCmec cassette, the rate of bistability could vary as a function of growth phase. For instance, it decreased by more than five times (from approx. ≥ 2.5% to ,0.5%; P,0.0001, unpaired t-test) between the logarithmic and stationary growth phases in S. aureus N315 and coagulase-negative Staphylococcus RP62A. Moreover, stress conditions such as high temperature or Expression of cassette chromosome recombinases 755 JAC treatment with mutagenic mitomycin C also showed some strain-specific trends toward increased rates of bistability, as apparent in Figure 4 . Therefore, considering the fact that bistability was affected by various environmental stress conditions it is possible that excision of SCCmec is regulated in a way similar to the excision of other MGEs or bacteriophages. Since major differences between the genomes of S. aureus strains lay in their MGEs, this could account for differences in ccrAB expression in different genetic backgrounds.
The fact that frequency of bistability decreased in late growth was consistent with a recent study showing that spontaneous excision of SCCmec in MRSA N315 occurred transiently and early in the logarithmic growth phase, and much less thereafter. 33 These results were obtained by determining the proportion of chromosomes from which the SCCmec cassette had been excised compared with total bacterial chromosomes at different timepoints during growth. On the other hand, the present experiments did not reveal an increase in ccrAB promoter activity during treatment with b-lactams, as was previously described for transcription of ccrA (using b-galactosidase and quantitative RT-PCR) after exposure to b-lactams and vancomycin. 16 However, the two studies differed in design in several ways that may render them complementary rather than contradictory. One of them is that we cloned the promoter region between the start of ccrAB and its preceding open reading frame, whereas Higgins et al. 16 added the first 21 bp of the ccrA gene plus 20 bp of the preceding open reading frame to this region. Therefore, it is conceivable that this larger 'promoter region' contained additional regulatory elements that could alter ccrAB promoter activity. Another difference was related to the induction protocols. Indeed, while Higgins et al. 16 looked at promoter activity and mRNA expression 15 min after antibiotic addition or temperature shift to 428C, the present study determined promoter expression in cultures that had experienced much more prolonged exposure to experimental stresses, i.e. throughout growth. Thus, one cannot exclude that ccrAB activity was punctually increased at the time of stress exposure, as in the Higgins et al. 16 study, but returned to baseline afterwards. Moreover, the present study determined the heterologous 'on' or 'off' activity of the ccrAB promoter, whereas Higgins et al. 16 measured the sum of all of these individual activities. Although both studies used low copy number plasmids (with a range of approx. 15 to 22 copies per cell), these measurements are not strictly comparable and are amenable to methodology biases. A more thorough comparison would have required integrating each individual data point of light intensity produced by the flow cytometry analysis in the present study. This analysis was attempted, but did not modify the overall results.
Taken together, the most important common message of the two experimental works is that activation of ccrAB expression does occur at a substantial rate in vivo and is affected by environmental stresses. Moreover, the present results add the notion of heterogeneous gene expression and bistability to the system, and suggest that ccrAB activity depends on the microbial background. Therefore, both environmental factors and bacterial background are pertinent with regard to SCCmec mobilization, and there might be more or fewer good donors and good recipients present in the environment. In order to achieve a more comprehensive view of SCCmec transfer, further work should focus on the molecular mechanisms driven by these two factors as well as on the mechanism (general phage transduction?) underlying the transfer of SCCmec from one cell to another.
